Recent Headlines
Within Pharmaceuticals
expEDIum Announces Successful Partnership with Medical Billing Service & Long-Term Care Medical Group, Inc.
Expanding its footprint in the healthcare industry, expEDIum is excited to announce the successful collaboration with Long-Term Care Medical Group, Inc. The partnership, initiated in October 2022, has flourished into a dynamic relationship, with Ms. Balwinder Bains, owner of the Medical Billing... - February 08, 2024 - expEDIum
Flow Circuits and Rapid Fluidics Ltd. Announce Partnership to Drive Microfluidic Innovation
Flow Circuits design platform and Rapid Fluidics 3D Print capabilities perfectly complement each other for rapid fluidic system development. Combined they empower researchers in diverse markets such as Pharmaceutical & Life Sciences Research, Point of Care Testing and Clinical Diagnostics, and Environment and Industrial Analytics. - February 05, 2024 - Rapid Fluidics Ltd
Accelerating Drug Discovery: Life Science and IT Leaders Explore the Power of Artificial Intelligence April 15-17 in Boston
AI to Take Center Stage at Bio-IT World Conference & Expo, the Hub for Pharmaceutical, Biotech and IT Collaboration - February 04, 2024 - Cambridge Healthtech Institute
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Creative Diagnostics has announced its extensive portfolio of AAV Reagent Solutions to support researchers. - February 04, 2024 - Creative Diagnostics
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics is pleased to announce the launch of its Serum Plate Agglutination Test. - February 04, 2024 - Creative Diagnostics
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics has announced the launch of Aflatoxin Test Reagents to detect harmful mycotoxins in various food products. - February 04, 2024 - Creative Diagnostics
Patient Experience and Satisfaction with Electronic Consent, Onboarding, and Diaries in Clinical Trials Report
New Market Research Shows Different Patient Preferences for Electronic Diaries - January 31, 2024 - Life Science Strategy Group, LLC
New Sustainable Lyophilization Technology Uses Supercritical CO2
The Thar group of companies have been using CO2 for extraction, purification, particle design and encapsulation for many years but recent developments point to a need for sustainable methods for drying APIs, intermediates, excipients and biologics at relatively low temperatures. 'Big Pharma' has depended on Thar for SFC tools in drug discovery but lyophilization will likely be used in manufacturing too. - January 28, 2024 - Thar Process, LLC
George W. Denninghoff Appointed EVP, Americas at Simms & Associates
Simms & Associates proudly welcomes George W. Denninghoff as Executive Vice President, Americas. With 25+ years of success in driving revenues and fostering customer satisfaction, George aligns his expertise with the company's North American growth goals. CEO Amanda Simms sees his appointment as pivotal in advancing Simms & Associates' global leadership in workforce management. - January 26, 2024 - Simms & Associates
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics has announced the launch of its new Robenidine Test Reagents for the detection of robenidine residues. - January 26, 2024 - Creative Diagnostics
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics has announced new Minimum Doubling Time (MDT) services to measure the effectiveness of antibacterial compounds. - January 26, 2024 - Creative Diagnostics
Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research
Creative Diagnostics has announced P53 and TP53 antibodies and solutions to support cancer research. - January 26, 2024 - Creative Diagnostics
Huntington Study Group Announces 2024 Annual Meeting
The Huntington Study Group® (HSG), together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), is pleased to announce that its annual meeting for 2024 is slated to take place from November 6-9 at the... - January 22, 2024 - Huntington Study Group
The Aesthetic Institute Announces Comprehensive Clinical Trial Programs in Advanced Aesthetic Techniques
The Aesthetic Institute is a leading center for medical aesthetics and anti-aging medicine, founded by Dr. Adam Summers, who is ranked by Newsweek as one of the nation’s top plastic surgeons. The Institute has launched an expanded clinical trial program to test new technologies and protocols in various aesthetic treatments, such as chemical peels, laser hair removal, and laser skin resurfacing that is now open to the general public. - January 22, 2024 - The Aesthetic Institute
Johari Digital Healthcare Limited Hosts Successful Webinar on Design for Manufacturing (DFM) for Medical Devices
Johari Digital Healthcare hosted a successful webinar on "Building Cost-effective Medical Devices through Design for Manufacturing." The 60-minute event discussed challenges in balancing cost and product robustness, featuring real-world case studies. Speakers highlighted early DFM benefits, such as cost reduction and faster time-to-market. - January 22, 2024 - Johari Digital Healthcare Ltd.
Impact of the In Vitro Diagnostic Regulation on Clinical Trials in the EU and CRO Outsourcing Report
IVDR Delays Driving Trial Sponsors to Actively Seek Alternative Site and CRO Outsourcing Strategies - January 17, 2024 - Life Science Strategy Group, LLC
NuvOx Pharma Announces Issuance of a New Patent
NuvOx Pharma has been issued US Patent No. 11,857,627, entitled “Fractionated Radiotherapy and Chemotherapy with an Oxygen Therapeutic.” - January 14, 2024 - NuvOx Therapeutics
New Ultra-Thin, Compact Low-Height, Low-Frequency Vibration Isolation Platform Adapts to Space Constraints in Critical Micro- and Nano-Microscopy
At about 2-1/2 inches in height, while isolating vibrations as low as 1 hertz, the new completely-passive Negative-Stiffness tabletop vibration isolation platform – developed by Minus K Technology – provides the industry’s thinnest low-height, low-frequency isolator for Microscopy (SPM, SEM, AFM, etc.), Micro-Hardness and Nano-Indenter Testing, Laser/Optical Systems, Biology/Neuroscience Systems, Spacecraft Ground Testing, Analytical Balances, Audio Reproduction, Vacuum & Cleanroom applications. - January 10, 2024 - Minus K Technology Inc.
Zifo Named Fastest Growing Technology Company in Deloitte Technology Fast 50 India 2023
Zifo has bagged this award for the 11th consecutive time. - December 20, 2023 - Zifo
ALPCO Announces the Commercial Launch of Its FDA 510(K) Cleared Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) diagnostic solutions. In July... - December 19, 2023 - ALPCO
Johari Digital Healthcare Ltd. Clinches Prestigious "Pharmaceutical & Healthcare MSME of the Year" Award at ET MSME Awards 2023
Johari Digital Healthcare Ltd. has clinched the esteemed "Pharmaceutical & Healthcare MSME of the Year" award at the ET MSME Awards 2023 in New Delhi. Celebrating the resilience of India's MSME sector, the event recognized Johari Digital Healthcare Ltd. for its exceptional contributions to healthcare, particularly in manufacturing and research & development. - December 18, 2023 - Johari Digital Healthcare Ltd.
expEDIum Introduces Office EHR and InstaPay, Along with Strategic Rebranding
Expanding its healthcare technology offerings, iTech announces expEDIum Office EHR, a robust Electronic Health Records (EHR) solution, alongside the unveiling of expEDIum InstaPay (eIP) for patient online payment convenience. This move signifies iTech's commitment to delivering practical,... - December 17, 2023 - expEDIum
Empowering Data Privacy: GENINVO Offers Anonymization as a Service
GENINVO, a leading provider of life science product and business solutions announced the offering of its on-demand service Anonymization as a Service. GENINVO a trailblazer in data privacy solutions, is excited to introduce its ground-breaking offering, Anonymization as a Service. With data... - December 14, 2023 - GenInvo, Inc.
Hexa Global Ventures Unveils TalentEdgeAI: a Revolutionary Solution to Transform Talent Acquisition and Staffing
TalentEdgeAI is revolutionizing the HR tech landscape by offering a unified platform specifically designed for mid-sized employers and staffing firms. It is providing a seamless, AI-driven solution that intelligently analyzes labor market trends, pinpoints ideal candidates, and optimizes the interview process with the power of AI and machine learning. This doesn't streamline recruitment – it redefines it by accelerating the process, improving the experience, and increasing candidate quality. - December 13, 2023 - TalentEdgeAI
Huntington Study Group and Roche Collaborate on GENERATION HD2 Study
The Huntington Study Group together with its wholly-owned clinical research organization, HSG Clinical Research, Inc. (HSGCR), is pleased to announce a collaboration with Roche-Genentech to optimize our collective experiences in Huntington’s disease (HD) clinical research. Together we are... - December 13, 2023 - Huntington Study Group
Breakthrough Study by Microvascular Therapeutics Reveals Fibrin-Targeted Phase Shift Microbubbles as Promising Solution for Microvascular Obstruction
Microvascular Therapeutics, a trailblazing healthcare research and development company, announces a groundbreaking study on the treatment of Microvascular Obstruction (MVO) through sonoreperfusion. The study, led by Dr. John J. Pacella and his team at the Center for Ultrasound Molecular Imaging and... - December 13, 2023 - Microvascular Therapeutics, Inc.
Microvascular Therapeutics Selected as a Participant in the 2023 H7 BioCapital Accelerator Program
Microvascular Therapeutics (MVT), a clinical stage biopharma pioneering the potential of ultrasound in diagnostics and theranostics, has been selected to join the prestigious H7 Healthcare Accelerator 2023 Cohort, powered by H7 BioCapital. The program is renowned for providing a dynamic platform... - December 13, 2023 - Microvascular Therapeutics, Inc.
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics has announced the launch of a range of new reagents for the analysis of Dapsone in food. - December 13, 2023 - Creative Diagnostics
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing. - December 13, 2023 - Creative Diagnostics
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics has launched a portfolio of Macrophage Migration Inhibitory Factor (MIF) reagents for researchers. - December 13, 2023 - Creative Diagnostics
Booth Unveiling Soon: Creative Biolabs and Ingenious Antibody Products at AET US 2023
Creative Biolabs highlights its participation in the upcoming Antibody Engineering and Therapeutics US 2023 conference, taking place from December 13–16, 2023. The event will be held in San Diego. - December 07, 2023 - Creative Biolabs
QuBind.com Makes Major Strides in T-Cell Immunotherapy with Revolutionary AI Innovation
In just 18 months, the young startup QuBind.com has achieved a remarkable breakthrough in T-cell immunotherapy, developing an advanced AI stack that is set to revolutionize personalized medicine. This significant milestone, reached with predominantly bootstrap funding, support from friends, family, and a strategic investment from a handful general partners in the PE sector, underscores the company's innovative spirit and scientific prowess. - December 05, 2023 - QuBind Technologies Corp
Announcing the Ales for ALS™ Roadtrip Across America
Over the coming months, Ales for ALS™ will be traveling across the country in an RV to connect with brewers and beer drinkers – all in support of ALS research. - December 04, 2023 - ALS Therapy Development Institute
cyberelements Launches an Attractive Program for MSPs
Since its launch at the beginning of the year, cyberelements has met great success in Europe, delivering business performance with cyber trust, with its “ready in 3 minutes” platform. cyberelements solve the c-level executives’ impossible equation of speed to compliance, shortage... - December 04, 2023 - cyberelements
Blockchain in Healthcare Predictions 2024
The leading peer reviewed specialty journal, Blockchain in Healthcare Today Platform Approaches Journal (BHTY), has published its annual Predictions article for 2024. Subject matter experts forecast near term expectations for the healthcare industry. - December 02, 2023 - Blockchain in Healthcare Today
Medical Device Manufacturers Who Want to Understand the Requirements of the Uk’s New MHRA MORE Platform for Submissions of Device Related Incidents
Quality First International encourages all medical device manufacturers who want to understand the requirements of the UK’s new MORE platform for submissions of device related incidents to participate in their new webinar. - December 01, 2023 - Quality First International
Herb Llama Launches Plant-Based, Adaptogenic Superfood Supplements: a Revolution in Modern Holistic Wellness
Herb Llama, an American wellness company, has launched a new range of adaptogenic, plant-based superfood supplements targeting health-conscious adults. The company, driven by the motto "vitamins as nature intended," ensures its plant-based products align with modern holistic wellness. - November 30, 2023 - Herb Llama
Clear Choice Dermatology Expands to Longview, WA, with New Dermatology and Wound Care Clinic
Clear Choice Dermatology expands with a new clinic in Longview, Washington, featuring dermatology services and a Wound Care & Vascular Medicine division. Clear Choice Dermatology aims to deliver top-tier healthcare services to Longview, reaffirming its commitment to comprehensive dermatological, wound care, and vascular medicine solutions. - November 30, 2023 - Clear Choice Dermatology
eBacMap, LLC and Charm Sciences, Inc., Launch Automated API Integration of Charm’s ATP Data in the eBacMap® Environmental Monitoring and Reporting Platform
eBacMap, LLC, a software developer of environmental mapping, tracking and trending for the food manufacturing industry, in collaboration with Charm Sciences, Inc., a leading provider of real-time sanitation monitoring tests and other innovative food safety solutions, is proud to announce the launch... - November 30, 2023 - eBacMap
FF Biotherapeutics Announces Search for Angel Investment to Revolutionize Immunotherapy and Vaccine Development
FF Biotherapeutics, a pioneering biotech startup at the forefront of immunotherapy and vaccine development, today announced its active pursuit of Angel investment. This critical funding round aims to propel the development of its groundbreaking Synthetic Standardized Convalescent Plasma (SSCP) and... - November 29, 2023 - FF Biotherapeutics
SciCord Informatics Platform R3.0 Boron Release
SciCord is proud to announce a new release of its Cloud-based Laboratory Informatics Platform. - November 22, 2023 - SciCord
Huntington Study Group® Holds 30th Annual Meeting
The Huntington Study Group® (HSG®), a world leader in conducting clinical trials and providing educational programming for Huntington’s disease (HD), recently held its 30th annual meeting, HSG 2023, November 2-4 in Phoenix, AZ. Hundreds of scientists, industry partners, HSG research... - November 21, 2023 - Huntington Study Group
Performance Inspired Nutrition Partners with Delta Common to Sell PI Products Throughout India
This new partnership offers an exciting opportunity for PI to introduce its clean and natural products to millions. - November 17, 2023 - Performance Inspired Nutrition
Announcing the Recipients of the 2024 Wisconsin Titan 100
Titan CEO and headline sponsor Wipfli LLP are pleased to announce Ms. Ayla Annac, CEO/President of InvivoSciences, Inc. as a 2024 Wisconsin Titan 100. The Titan 100 program recognizes Wisconsin’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished... - November 08, 2023 - InvivoSciences
Novugen Pharma (USA) LLC Launches ANDA Approved Midodrine 2.5mg, 5mg & 10mg
Novugen Pharma (USA) LLC has launched Midodrine 2.5mg, 5mg and 10mg in the U.S. upon the approval from ANDA by FDA. Novugen’s Midodrine will be manufactured in Malaysia by Novugen Pharma Sdn. Bhd. Midodrine is indicated for the treatment of symptomatic orthostatic hypotension, a condition defined as a sudden drop in blood pressure upon standing from a sitting or supine position. - November 07, 2023 - Novugen
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics has announced the release of its new line of Carbamazepine Test Reagents. - November 04, 2023 - Creative Diagnostics
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics has recently launched a series of new Minimum Inhibitory Concentration (MIC) assay services for researchers. - November 04, 2023 - Creative Diagnostics
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has launched a range of antibodies, antigens and kits against CLDN6 to support researchers worldwide in preclinical and clinical safety/efficacy testing. CLDN6 may be involved in the development and... - November 04, 2023 - Creative Diagnostics
NAPHIA Elects Executive Leadership
The North American Pet Health Insurance Association’s (NAPHIA) Board of Directors recently held its bi-annual election to appoint its executive officers to a two-year term of service. - November 02, 2023 - NAPHIA - North American Pet Health Insurance Association
IC Formulations, Developer of A Better Gummy®, and Incredo LTD Announce an Exclusive Nutraceutical Gummy Partnership
IC Formulations, an innovative formulator and manufacturer of nutritional supplements and the developer of A Better Gummy®, gummy vitamins and Incredo LTD, a food tech company and developer of Incredo® Sugar, an award-winning sugar-based sugar reduction solution, announce an exclusive gummy... - October 29, 2023 - IC Formulations